Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

YTEK reported for 9 months of 2024 by RAS

11/1/24 YAKG

Novatek reports for 9 months of 2024 by RAS

11/1/24 NVTK

Board of Directors of Europlan recommended dividends

11/1/24 LEAS

IVA Technologies revenue grew by 52% in 9 months

11/1/24 IVAT

Pharmsintez reported for 9 months of 2024 by RAS

10/31/24 LIFE

EL5-Energo reported for 9 months of 2024 by IFRS

10/31/24 ELFV

Rosseti North-West reported for 9 months of 2024 by RAS

10/31/24 MRKZ

Polyus received the first ton of gold from Sukhoi Log

10/31/24 PLZL

X5 reported for 9 months of 2024 by RAS

10/31/24 X5

Severstal reported for 9 months of 2024 by RAS

10/31/24 CHMF